Boonyong, N.; Charoenlap, N.; Tipanyo, P.; Grittanaanun, P.; Mongkolsuk, S.; Vattanaviboon, P.
Mutation of smeRv Renders Stenotrophomonas maltophilia Resistant to First-Line Antibiotics Trimethoprim/Sulfamethoxazole and Levofloxacin. Antibiotics 2025, 14, 550.
https://doi.org/10.3390/antibiotics14060550
AMA Style
Boonyong N, Charoenlap N, Tipanyo P, Grittanaanun P, Mongkolsuk S, Vattanaviboon P.
Mutation of smeRv Renders Stenotrophomonas maltophilia Resistant to First-Line Antibiotics Trimethoprim/Sulfamethoxazole and Levofloxacin. Antibiotics. 2025; 14(6):550.
https://doi.org/10.3390/antibiotics14060550
Chicago/Turabian Style
Boonyong, Nuchjaree, Nisanart Charoenlap, Parinya Tipanyo, Pitthawat Grittanaanun, Skorn Mongkolsuk, and Paiboon Vattanaviboon.
2025. "Mutation of smeRv Renders Stenotrophomonas maltophilia Resistant to First-Line Antibiotics Trimethoprim/Sulfamethoxazole and Levofloxacin" Antibiotics 14, no. 6: 550.
https://doi.org/10.3390/antibiotics14060550
APA Style
Boonyong, N., Charoenlap, N., Tipanyo, P., Grittanaanun, P., Mongkolsuk, S., & Vattanaviboon, P.
(2025). Mutation of smeRv Renders Stenotrophomonas maltophilia Resistant to First-Line Antibiotics Trimethoprim/Sulfamethoxazole and Levofloxacin. Antibiotics, 14(6), 550.
https://doi.org/10.3390/antibiotics14060550
